echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Clin Gastroenterology H: The postoperative recurrence rate of Crohn's disease and the effect of immunosuppression and biological therapy on its recurrence

    Clin Gastroenterology H: The postoperative recurrence rate of Crohn's disease and the effect of immunosuppression and biological therapy on its recurrence

    • Last Update: 2021-04-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Intestinal lesions in Crohn's disease (CD) patients can easily develop into narrow or penetrating lesions.


     

     


     

     


     

     

    This study shows that the use of immunosuppressants and tumor necrosis factor antagonists to treat asymptomatic endoscopic CD recurrence patients does not reduce the long-term clinical recurrence risk of patients with Rutgeerts score i2, but drug treatment for patients with i3 or i4 Can significantly reduce the risk of postoperative recurrence.


     

     

     

    Original source:

    Pauline Rivière.


    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.